Asian Offerings Again Outpace Western Biopharma IPOs In Q4

Full-Year 2025: 13 In US, Europe Vs. 20 In China, South Korea

 
• By Mandy Jackson
  
IPOs in Asia outpaced US and European offerings (Shutterstock)

More from Financing

More from Business